Chlorhexidine mouth rinse
PreclinicalSmall molecule
Chlorhexidine mouth rinse is one of 13 small molecule programs targeting Chronic Periodontitis. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
12
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
14 competitors in Chronic Periodontitis
#DrugCompanyPhaseTrials
1Avelox
BayerApproved
Amoxil
GGlobal Antibiotics Research and Development Partnership
Approved
Zocor
OOrganon and Co
Approved
Minocin
TTriax
Approved
Singulair
OOrganon and Co
Approved
Fosamax
OOrganon and Co
Approved
Glucophage
EMD SeronoApproved
Verazinc
FFakultas Kedokteran Universitas Indonesia
Preclinical
Lactobacillus Reuteri
TTulane University School of Medicine
Preclinical
Chlorhexidine mouth rinse
UUniversity of Washington
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Chlorhexidine mouth rinse. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Washington